HIV-1 Tat biosensor: Current development and trends for early detection strategies

Biosens Bioelectron. 2016 Apr 15:78:358-366. doi: 10.1016/j.bios.2015.11.067. Epub 2015 Nov 25.

Abstract

Human immunodeficiency virus (HIV) has infected almost 35 million people worldwide. Various tests have been developed to detect the presence of HIV during the early stages of the disease in order to reduce the risk of transmission to other humans. The HIV-1 Tat protein is one of the proteins present in HIV that are released abundantly approximately 2-4 weeks after infection. In this review, we have outlined various strategies for detecting the Tat protein, which helps transcribe the virus and enhances replication. Detection strategies presented include immunoassays, biosensors and gene expression, which utilize antibodies or aptamers as common probes to sense the presence of Tat. Alternatively, measuring the levels of gene transcription is a direct method of analysing the HIV gene to confirm the presence of Tat. By detection of the Tat protein, virus transmission can be detected in high-risk individuals in the early stages of the disease to reduce the risk of an HIV pandemic.

Keywords: Antibody; Aptamer; Biosensor; HIV-1 Tat.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies / chemistry
  • Antibodies / immunology
  • Aptamers, Nucleotide / chemistry
  • Biosensing Techniques*
  • HIV Infections / diagnosis*
  • HIV Infections / virology
  • HIV-1 / immunology
  • HIV-1 / isolation & purification*
  • Humans
  • tat Gene Products, Human Immunodeficiency Virus / immunology
  • tat Gene Products, Human Immunodeficiency Virus / isolation & purification*

Substances

  • Antibodies
  • Aptamers, Nucleotide
  • tat Gene Products, Human Immunodeficiency Virus